세계의 호흡기 질환 검사 시장 규모는 2024년 60억 1,000만 달러로, 2030년까지 연평균 성장률(CAGR)은 5.72%를 나타낼 전망입니다.
호흡기 진단은 폐 기능 및 관련 호흡 과정을 임상적으로 평가하여 다양한 폐 질환을 진단하고 관리하는 것을 포함합니다. 이러한 진단은 천식, 만성 폐쇄성 폐 질환(COPD), 폐암, 기관지염, 폐 섬유증 등 다양한 질환을 조기 발견하는 데 중요한 역할을 합니다. 호흡기 진단에는 기계적, 영상, 분자적 검사 방법 등 다양한 도구와 기술이 사용됩니다. 일반적인 검사 방법에는 폐 기능과 폐 용량을 측정하여 폐쇄성 및 제한성 폐 질환을 평가하는 스피로메트리와 혈중 산소 포화도를 평가하는 옥시메트리가 포함됩니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 60억 1,000만 달러 |
| 시장 규모 : 2030년 | 83억 2,000만 달러 |
| CAGR(2025-2030년) | 5.72% |
| 급성장 부문 | 영상 검사 |
| 최대 시장 | 북미 |
경피적 이산화탄소(CO2) 모니터링은 피부를 통해 혈중 CO2 수치를 측정하여 의사가 호흡 효율을 평가하는 데 사용됩니다. 또 다른 기술인 SNIP(sniff nasal inspiratory pressure)는 특히 신경근 장애가 있는 환자의 흡기 근육의 힘을 평가하기 위해 사용됩니다. 흉부 X선 촬영과 컴퓨터 단층촬영(CT)과 같은 영상 검사는 폐 구조를 시각화하고 종양, 감염, 섬유화 등을 식별하며 추가 치료를 안내하는 데 필수적입니다. 이러한 영상 도구는 정확한 진단과 치료 계획 수립을 지원하는 상세한 정보를 제공합니다. 특정 경우, 수면 연구는 주간 피로, 큰 코골이, 수면 중 호흡 중단 등 증상을 보이는 환자의 폐쇄성 수면 무호흡증이나 야간 저환기증을 진단하기 위해 수행됩니다. 이 연구는 수면 중 호흡 패턴, 산소 수준, 기타 생리적 기능을 모니터링합니다. 호흡기 진단은 폐 질환의 조기 발견, 모니터링, 관리에 필수적입니다. 이는 적시 개입을 가능하게 할 뿐만 아니라 환자의 호흡 프로필에 따라 치료 전략을 맞춤화하는 데 도움을 주어 임상 결과와 삶의 질을 개선합니다.
호흡기 질환의 증가하는 부담
높은 비용 및 숙련된 전문가의 부족
POCT(Point-of-Care Testing)의 확대
Global Respiratory Disease Testing Market was valued at USD 6.01 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.72% through 2030F. Respiratory diagnostics involve the clinical assessment of lung function and related respiratory processes to identify and manage various pulmonary conditions. These diagnostics play a vital role in detecting disorders such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis.A broad spectrum of tools and techniques is used in respiratory diagnostics, encompassing mechanical, imaging, and molecular testing approaches. Common procedures include spirometry, which measures airflow and lung volumes to assess obstructive and restrictive lung diseases, and oximetry, which evaluates blood oxygen saturation levels.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 6.01 Billion |
| Market Size 2030 | USD 8.32 Billion |
| CAGR 2025-2030 | 5.72% |
| Fastest Growing Segment | Imaging Tests |
| Largest Market | North America |
Transcutaneous carbon dioxide (CO2) monitoring is used to measure CO2 levels in the blood through the skin, helping clinicians assess respiratory efficiency. Another technique, sniff nasal inspiratory pressure (SNIP), is employed to evaluate inspiratory muscle strength, especially in patients with neuromuscular disorders. Imaging methods such as chest X-rays and computed tomography (CT) scans are crucial for visualizing lung structure, identifying tumors, infections, or fibrosis, and guiding further interventions. These imaging tools provide detailed information that supports accurate diagnosis and treatment planning. In specific cases, sleep studies are conducted to diagnose conditions like obstructive sleep apnea and nocturnal hypoventilation, especially in patients exhibiting symptoms such as daytime fatigue, loud snoring, or interrupted breathing during sleep. These studies monitor breathing patterns, oxygen levels, and other physiological functions during sleep. The respiratory diagnostics are essential for early detection, monitoring, and management of pulmonary diseases. They not only facilitate timely intervention but also help in tailoring treatment strategies based on the individual patient's respiratory profile, thereby improving clinical outcomes and quality of life.
Key Market Drivers
Growing Burden of Respiratory Diseases
The increasing prevalence of respiratory diseases is a significant driver for market growth. For instance, according to a 2023 article, Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition linked to serious complications such as cardiovascular disease, respiratory failure, and lung cancer. Key risk factors include smoking, air pollution (indoor and outdoor), genetic predisposition, occupational exposures, and infections during childhood or adulthood. Factors such as the rise in smokers, alcohol consumption, sedentary lifestyle habits, and stressful routines have led to an increase in cases of COPD and other severe respiratory conditions, including lung cancer. The technological advancements in respiratory diagnostic testing, such as the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for COPD diagnosis and outpatient management, have positively impacted market growth. The growing demand for respiratory diagnostics devices in privately-owned hospitals and healthcare centers, along with the efforts of government and non-governmental organizations (NGOs) to improve access to quality healthcare facilities, are key drivers of the respiratory diagnostics market. Respiratory symptoms rank among the primary reasons for seeking medical consultation in primary healthcare centers. Key preventable chronic respiratory disorders include asthma, COPD, allergic rhinitis, sleep apnea, and tuberculosis (particularly multi-drug resistant tuberculosis). As of September 2022, the CDC reported 873,000 emergency department visits for COPD in the United States in 2020, with 5% of adults receiving a new diagnosis of COPD, emphysema, or chronic bronchitis. These statistics underscore the growing burden of respiratory diseases on society, which is expected to drive the demand for respiratory disease testing and fuel market growth.
Key Market Challenges
High Cost and Lack of Skilled Professionals
The significant cost associated with diagnostic procedures poses a major challenge to the growth of the global respiratory diagnostics market during the forecast period. The rapid technological advancements in the field have led to a shortage of qualified specialists. The lack of competent experts has greatly hindered the proper handling of instruments and the execution of procedures. The cost associated with setting up and maintaining advanced respiratory disease testing facilities, including purchasing equipment, reagents, and maintaining quality control, can be substantial. This cost burden can discourage healthcare providers from investing in the necessary infrastructure. The high cost of establishing and operating testing facilities can lead to geographic disparities in access. Remote or underserved areas may lack the resources needed to offer comprehensive respiratory disease testing, limiting access for vulnerable populations. The specialized nature of respiratory disease testing requires trained and skilled laboratory professionals who can operate and interpret complex diagnostic equipment accurately. A shortage of such professionals can lead to delays in testing, misinterpretation of results, and overall reduced testing capacity.
Key Market Trends
Point-of-Care Testing (POCT) Expansion
The expansion of point-of-care testing for respiratory diseases will enable rapid and convenient testing in various healthcare settings, such as clinics, pharmacies, and community health centers. POCT devices will facilitate timely diagnosis and monitoring, especially in resource-limited environments. POCT devices provide rapid results, often within minutes, allowing healthcare providers to make timely decisions about patient care. In cases of acute respiratory conditions, such as respiratory infections or exacerbations of chronic diseases, quick diagnosis can lead to immediate initiation of appropriate treatment. Traditional laboratory testing involves transporting samples, processing, and result reporting, which can lead to delays.
POCT devices minimize turnaround time, enabling healthcare providers to quickly assess a patient's respiratory status and make informed decisions without waiting for external laboratory results. As technology continues to advance, the development of accurate, user-friendly, and affordable POCT devices for respiratory diseases has the potential to revolutionize healthcare delivery, particularly in settings where access to traditional laboratory testing is limited. It empowers healthcare providers with actionable information and empowers patients to actively manage their respiratory health, contributing to better overall healthcare outcomes.
In this report, the Global Respiratory Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Disease Testing Market.
Global Respiratory Disease Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: